Recent Advances in Antibody-Drug Conjugates for the Treatment of Cancer

Session 7:  Recent Advances in Antibody-Drug Conjugates for the Treatment of Cancer

1:20 PM  2:30 PM

Moderator:
Marco Gottardis, PhD
Janssen Research & Development, LLC

Introduction
Marco Gottardis, PhD
Janssen Research & Development, LLC

Antibody Drug Conjugates: From Early Stage Research to Clinically Approved Drugs
Peter Senter, PhD
Seattle Genetics

Novel Approaches to Development of Antibody-Drug Conjugates for the Treatment of Cancer
Yuuri Hashimoto, PhD
Daiichi Sankyo Co., Ltd.

PSMA Antibody Targeted Amanitin Conjugate (PSMA-ATAC): Introducing a Novel Mode of Action into Prostate Cancer Therap
George Badescu, PhD
Heidelberg Pharma AG

Live Session Discussion

Friday, October 23, 2020

82 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate